Project CBD Newsletter: FDA CBD Gummy Recall, Magic Mushroom Edibles Contain No Psilocybin, CBD for Obesity, Acupuncture and the Endocannabinoid System, and Psychedelic-Associated Depersonalization Disorder
CBD News

Project CBD Newsletter: FDA CBD Gummy Recall, Magic Mushroom Edibles Contain No Psilocybin, CBD for Obesity, Acupuncture and the Endocannabinoid System, and Psychedelic-Associated Depersonalization Disorder

This week’s newsletter covers a major CBD product recall, surprising findings about “magic mushroom” edibles, promising preclinical research on CBD for metabolic health, acupuncture’s link to the endocannabinoid system, and a review of psychedelic-associated depersonalization […]